Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis

Sung Min Cho, Ho Jeong Kwon

Research output: Contribution to journalReview articlepeer-review

19 Citations (Scopus)


Sphingolipid metabolism plays an important role in determining the fate of a cell. Among several sphingolipid metabolites, ceramide is a key player in intracellular signal transduction. Ceramide is usually converted to various metabolites such as sphingomyelin, sphingosine, ceramide-1-phosphate, and glucosylceramide. If ceramide is accumulated in the cell, it induces apoptosis. On the other hand, its metabolite sphingosine is converted to sphingosine-1-phosphate (S1P), which promotes angiogenesis via G protein coupled receptor signaling. Therefore, the equilibrium in ceramide and S1P levels in cells plays an important role in angiogenesis as well as cell death. Acid ceramidase (AC) is a promising target protein in the development of multi-targeted anticancer drugs as its inhibition can simultaneously inhibit angiogenesis via the Akt and ERK 1/2 pathway and limit cancer growth through ceramide-induced apoptosis. Although some inhibitors of AC have been reported, they have not been proven effective for human therapy. Recent advancement in the elucidation of AC structure will facilitate the development of better inhibitors for treating human diseases.

Original languageEnglish
Pages (from-to)232-243
Number of pages12
JournalArchives of pharmacal research
Issue number3
Publication statusPublished - 2019 Mar 1

Bibliographical note

Publisher Copyright:
© 2019, The Pharmaceutical Society of Korea.

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis'. Together they form a unique fingerprint.

Cite this